- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Opaque Weighted Bottle in Finland
Total 291 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Canadian Cancer Trials Group; Division of Cancer... and other collaboratorsActive, not recruitingBreast CarcinomaUnited States, Canada, Puerto Rico, Guam
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, United Kingdom, Canada, Denmark, Finland, Serbia, Poland, Japan, South Africa, Ireland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol Specific | Cachexia | Lymphoproliferative DisorderUnited States, Canada
-
Novo Nordisk A/SRecruitingObesity | OverweightBrazil, United States, Argentina, Australia, Canada, Denmark, Germany, Greece, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, South Africa, Sweden, Taiwan, Thailand, United Kingdom, Algeria, Croatia, Finland, India, Ireland
-
Orexigen Therapeutics, IncCompletedObesity | OverweightUnited States
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedRetinopathy of Prematurity | Bronchopulmonary Dysplasia (BPD) | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Eli Lilly and CompanyRecruitingObesity | Overweight and ObesityUnited States
-
Rhythm Pharmaceuticals, Inc.Active, not recruitingGenetic ObesityUnited States, Spain, Netherlands, Germany, United Kingdom, Canada, Israel, Greece
-
ShionogiCompleted
-
Boston Scientific CorporationCompletedAtherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial DiseaseUnited States, Belgium, Canada, Japan, Austria, New Zealand
-
Western University, CanadaCanadian Institutes of Health Research (CIHR); Public Health Agency of Canada...CompletedObesity | OverweightCanada, United States
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Eli Lilly and CompanyRecruiting
-
Eli Lilly and CompanyRecruitingObesity | Overweight and ObesityUnited States
-
PfizerTerminatedObesityUnited States, Australia, Canada, Brazil, Slovakia, Czech Republic, Argentina, Germany, Mexico, United Kingdom, Sweden
-
Rhythm Pharmaceuticals, Inc.RecruitingObesity | Genetic ObesityUnited States, Spain, Germany, Netherlands, United Kingdom, Greece, Puerto Rico, Canada, France, Israel
-
ShionogiCompleted
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedInfant, Newborn, Diseases | Premature Birth | Retinopathy of Prematurity | Bronchopulmonary Dysplasia | Other Preterm Infants | Infant, Small for Gestational AgeUnited States
-
PfizerActive, not recruitingFatigue | Colorectal Cancer | Pancreatic Cancer | Cachexia | Non-small Cell Lung Cancer | Loss of AppetiteChina, United States, Canada, Hungary, Australia, Slovakia, Japan, Taiwan, Bulgaria, Poland, Spain, Czechia
-
Orexigen Therapeutics, IncTerminated
-
Boehringer IngelheimActive, not recruitingObesityUnited States, Korea, Republic of, Belgium, Australia, China, Poland, Japan, Finland, Germany, Canada, Netherlands, New Zealand, Sweden, United Kingdom
-
Novo Nordisk A/SCompletedOverweight or Obesity | Metabolism and Nutrition DisorderUnited States, India, Mexico, Russian Federation, United Kingdom, Canada, Denmark, Finland, Belgium, Japan, Taiwan, France, Poland, Germany, Bulgaria, Argentina, Puerto Rico
-
Orexigen Therapeutics, IncCompletedObesity | Diabetes Mellitus, Type 2 | OverweightUnited States
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightUnited States, Taiwan, India, China, Japan, Mexico, Brazil, Puerto Rico, Argentina, Russian Federation
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
SanofiCompletedObesity | Diabetes Mellitus, Non-Insulin-Dependent | Obesity in DiabetesUnited States, France, Canada, Poland, Germany, Netherlands, Belgium, Czech Republic, Argentina, Finland, United Kingdom
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
PfizerTerminatedObesity | Diabetes MellitusUnited States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
-
Boehringer IngelheimRecruitingObesity | Diabetes Mellitus, Type 2United States, Korea, Republic of, Belgium, Spain, China, Australia, Hungary, Canada, Czechia, Poland, New Zealand, Denmark, Finland, Germany, Greece, Netherlands, Sweden, Japan, United Kingdom
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Malaysia, Spain, United Kingdom, Thailand, India, Turkey, Mexico, Canada, Bulgaria, Argentina, Germany, France, Poland, South Africa, Brazil, Colombia, Denmark, Ireland, Japan
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Poland, Israel, Italy, Mexico, Spain, Canada, Denmark, Finland, United Kingdom, France, Netherlands, Austria, Belgium, Argentina, Russian Federation, Serbia, Turkey, Switzerland, Germany, South Africa, Hungary, Hong Kong and more
-
Eli Lilly and CompanyRecruitingOverweight and ObesityUnited States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Type 2 DiabetesUnited States, China, Australia, India, Germany, Brazil, Greece, Argentina, Korea, Republic of, Czechia, Puerto Rico
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Eli Lilly and CompanyRecruitingObesity | Overweight | Obstructive Sleep Apnea | Type 2 DiabetesAustralia, United States, Mexico, Spain, India, Brazil, Romania, Taiwan, Argentina
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Slovakia, Hungary, Brazil
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Romania, Brazil, Czechia, Germany, Mexico, Argentina, Greece, Slovakia